Lee, Daniel S. W.
Choi, Chang-Hyun http://orcid.org/0000-0002-9091-3932
Sanders, David W.
Beckers, Lien
Riback, Joshua A. http://orcid.org/0000-0002-1516-4484
Brangwynne, Clifford P. http://orcid.org/0000-0002-1350-9960
Wingreen, Ned S. http://orcid.org/0000-0001-7384-2821
Funding for this research was provided by:
National Science Foundation (DCE-1656466, PHY-1734030)
Howard Hughes Medical Institute
U.S. Department of Health & Human Services | National Institutes of Health (U01 DA040601)
Article History
Received: 2 March 2022
Accepted: 12 December 2022
First Online: 2 February 2023
Competing interests
: C.P.B. is a founder and consultant for Nereid Therapeutics. All other authors declare no competing interests.